Novo Nordisk’s Diabetes Franchise Bears The Weight Of Disappointing Obesity Sales

As Manufacturing Issues Continue

 
• By Ayisha Sharma
  
Diabetes monitoring and healthcare. Close up top down view of glucose meter, drug pills and syringe on blue background with copy space.
Novo Is Known For Its Diabetes Franchise But Wegovy Is Touted As A Blockbuster Obesity Drug. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business